Active Ingredient(s): Aliskiren + Valsartan
FDA Approved: * September 16, 2009
Pharm Company: * NOVARTIS PHARMS
Category: Blood Pressure

Aliskiren (brand names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension.[1] While used for high blood pressure, other better studied medications are typically recommended due to concerns of higher side effects and less evidence of benefit.[2] In December 2011, Novartis halted a trial of the drug after discovering increased nonfatal stroke, kidney complications, high blood pota... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion